Novo Nordisk

Summary

Novo Nordisk is a business^[1]. It ranks in the top 0.82% of business entities by monthly Wikipedia readership (4,823 views/month, #243 of 29,529).^[2]

Key Facts

• Novo Nordisk was a member of C40 Cities Climate Leadership Group^[3].
• Novo Nordisk is in the country of Denmark^[4].
• Novo Nordisk is in the country of DK^[5].
• Novo Nordisk's instance of is recorded as business^[6].
• Novo Nordisk's instance of is recorded as enterprise^[7].
• Novo Nordisk's instance of is recorded as public company^[8].
• Novo Nordisk's instance of is recorded as biopharmaceutical company^[9].
• Novo Nordisk's founder is recorded as Hans Christian Hagedorn^[10].
• Novo Nordisk's founder is recorded as August Krogh^[11].
• Novo Nordisk's founder is recorded as Marie Krogh^[12].
• Novo Nordisk's founder is recorded as August Kongsted^[13].
• Novo Nordisk is owned by Novo Holdings^[14].
• Novo Nordisk is owned by Novo Nordisk Foundation^[15].
• Novo Nordisk's headquarters location is recorded as Bagsværd^[16].
• Novo Nordisk's chief executive officer is recorded as Lars Fruergaard Jørgensen^[17].
• Novo Nordisk's chief executive officer is recorded as Mike Doustdar^[18].
• Novo Nordisk's child organization or unit is recorded as Novo Nordisk (United States)^[19].
• Novo Nordisk's child organization or unit is recorded as Novo Nordisk (Switzerland)^[20].
• Novo Nordisk's child organization or unit is recorded as Novo Nordisk (Germany)^[21].
• Novo Nordisk's child organization or unit is recorded as Novo Nordisk s.r.o.^[22].
• Novo Nordisk's child organization or unit is recorded as Novo Nordisk (Algeria)^[23].
• Novo Nordisk's child organization or unit is recorded as NNE A/S^[24].
• Novo Nordisk's Commons category is recorded as Novo Nordisk^[25].
• Novo Nordisk's stock exchange is recorded as New York Stock Exchange^[26].
• Novo Nordisk's stock exchange is recorded as Nasdaq Copenhagen A/S^[27].

Product Details

The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.

GLEIF Golden Copy — Level 1 entity data

• Legal Entity Identifier (LEI): 549300DAQ1CVT6CXN342^[28]

• Registered legal name: Novo Nordisk A/S^[29]

• Legal jurisdiction: DK^[30]

• GLEIF entity category: GENERAL^[31]

• Legal form (ISO 20275 ELF): ZRPO^[32]

• Entity status: ACTIVE^[33]

• LEI registration status: ISSUED^[34]

• Entity created: 1931-11-28^[35]

• LEI first registered: 2013-09-10^[36]

• LEI last updated: 2025-12-22^[37]

• LEI next renewal: 2027-02-07^[38]

• Managing LOU: 549300O897ZC5H7CY412^[39]

• Registration authority: RA000170^[40]

• Authority entity ID: 24256790^[41]

• Conformity flag: CONFORMING^[42]

Body

Founding

Founders include Hans Christian Hagedorn^[10], August Krogh^[11], Marie Krogh^[12], and August Kongsted^[13]. Recorded inception include January 1, 1923^[43] and 1931-11-28^[44].

Identity

Novo Nordisk's official name is recorded as {'lang': 'da', 'text': 'it'}^[45].

Leadership

Chief executives include Lars Fruergaard Jørgensen^[17], a director^[46], b. 1966^[47], of Kingdom of Denmark^[48], awarded the Knight of the Order of the Dannebrog^[49] and Mike Doustdar^[18], a businessperson^[50], b. 1970^[51], of Austria^[52].

Operations

Novo Nordisk's headquarters location is recorded as Bagsværd^[16]. Its parent organization or unit is recorded as Novo Holdings^[53]. Subsidiaries include it (United States)^[19], a business^[54], in United States^[55], founded in 1923^[56], headquartered in Seattle^[57]; it (Switzerland)^[20]; it (Germany)^[21], a business^[58], in Germany^[59], founded in 1973^[60], headquartered in Mainz^[61]; it s.r.o.^[22], a business^[62], in Czech Republic^[63], founded in 1997^[64], headquartered in Prague^[65]; it (Algeria)^[23]; and NNE A/S^[24], a business^[66], in Denmark^[67], founded in 1991^[68], headquartered in Virum^[69].

Industry

Novo Nordisk's industry is recorded as pharmaceutical industry^[70].

Ownership

Owners include Novo Holdings^[14], a business^[71], in Denmark^[72], founded in 1999^[73], headquartered in Gentofte Municipality^[74] and Novo Nordisk Foundation^[15], a foundation^[75], in Denmark^[76], founded in 1989^[77], headquartered in Hellerup^[78]. Stock exchanges include New York Stock Exchange^[26] and Nasdaq Copenhagen A/S^[27]. Products include preproinsulin^[79], glucagon-like peptide-1 agonist^[80], glucagon^[81], growth hormone^[82], sex steroid^[83], and semaglutide^[84].

Brands and Namesakes

Things named for Novo Nordisk include Novo Nordisk Prize^[85], a science award^[86], in Denmark^[87], founded in 1963^[88].

Why It Matters

Novo Nordisk ranks in the top 0.82% of business entities by monthly Wikipedia readership (4,823 views/month, #243 of 29,529).^[2] It has Wikipedia articles in 25 language editions, a strong signal of global cultural recognition.^[89] It is known by 11 alternative names across languages and contexts.^[90]

Entities named for it include Novo Nordisk Prize^[85], a science award^[86], in Denmark^[87], founded in 1963^[88].